相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant p53 elicits context-dependent pro-tumorigenic phenotypes
Jennifer J. McCann et al.
ONCOGENE (2022)
RelB promotes the migration and invasion of prostate cancer DU145 cells via exosomal ICAM1 in vitro
Wenjing Li et al.
CELLULAR SIGNALLING (2022)
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
Sujun Chen et al.
NATURE CELL BIOLOGY (2021)
Prostate cancer hijacks the microenvironment
Phillip Thienger et al.
NATURE CELL BIOLOGY (2021)
Development of a Multiplex Immunohistochemistry Workflow to Investigate the Immune Microenvironment in Mouse Models of Inflammatory Bowel Disease and Colon Cancer
Lokman Pang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prostate cancer
Richard J. Rebello et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer
Yoshinori Yanai et al.
SCIENTIFIC REPORTS (2021)
Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts
Xiaohan Ren et al.
FRONTIERS IN IMMUNOLOGY (2021)
Mutant p53 in cell-cell interactions
Steven Pilley et al.
GENES & DEVELOPMENT (2021)
Evaluating the transcriptional fidelity of cancer models
Da Peng et al.
GENOME MEDICINE (2021)
Immune Checkpoint Inhibitors in Prostate Cancer
Shobi Venkatachalam et al.
CANCERS (2021)
Transcriptional landscape of PTEN loss in primary prostate cancer
Eddie Luidy Imada et al.
BMC CANCER (2021)
The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer
Camila Morais Melo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prostate cancer
Shahneen Sandhu et al.
LANCET (2021)
The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation
Timothy D. Martin et al.
SCIENCE (2021)
Prostate cancer in young men: An emerging young adult and older adolescent challenge
Archie Bleyer et al.
CANCER (2020)
PTEN Mouse Models of Cancer Initiation and and Progression
Yu-Ru Lee et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
Musaffe Tuna et al.
BRITISH JOURNAL OF CANCER (2020)
Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer
Matthieu Lacroix et al.
MOLECULAR METABOLISM (2020)
Systemic Management for Nonmetastatic Castration-resistant Prostate Cancer A Systematic Review and Network Meta-Analysis
Zefu Liu et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Emerging role of PTEN loss in evasion of the immune response to tumours
Thiago Vidotto et al.
BRITISH JOURNAL OF CANCER (2020)
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
Arjelle Decasa Agupitan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
Surendra Chaurasiya et al.
PLOS ONE (2020)
CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
Renlun Huang et al.
CELL DEATH & DISEASE (2020)
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
Simon P. Keam et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
Donald Freudenstein et al.
CANCERS (2020)
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2020)
Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging
Courtney Yong et al.
PLOS ONE (2020)
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
Rahul Mal et al.
FRONTIERS IN ONCOLOGY (2020)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
p53 nuclear accumulation as an early indicator of lethal prostate cancer
David I. Quinn et al.
BRITISH JOURNAL OF CANCER (2019)
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
Steffen Boettcher et al.
SCIENCE (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
PTEN-opathies: from biological insights to evidence-based precision medicine
Lamis Yehia et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
Sisi Chen et al.
NATURE COMMUNICATIONS (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression
Kimberley Kolijn et al.
CANCER RESEARCH (2018)
The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort
Simon P. Keam et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Cutting Edge: Check Your Mice-A Point Mutation in the Ncr1 Locus Identified in CD45.1 Congenic Mice with Consequences in Mouse Susceptibility to Infection
Youngsoon Jang et al.
JOURNAL OF IMMUNOLOGY (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Clinical implications of PTEN loss in prostate cancer
Tamara Jamaspishvili et al.
NATURE REVIEWS UROLOGY (2018)
Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue
Simon P. Keam et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2018)
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases
Yun Zhang et al.
NATURE COMMUNICATIONS (2018)
Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models
Disharee Nath et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Comparing Postnatal Development of Gonadal Hormones and Associated Social Behaviors in Rats, Mice, and Humans
Margaret R. Bell
ENDOCRINOLOGY (2018)
Why are there hotspot mutations in the TP53 gene in human cancers?
Evan H. Baugh et al.
CELL DEATH AND DIFFERENTIATION (2018)
Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein
Rasoul Pourebrahim et al.
GENES & DEVELOPMENT (2017)
MDM4 is a rational target for treating breast cancers with mutant p53
Panimaya Jeffreena Miranda et al.
JOURNAL OF PATHOLOGY (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
Evguenia M. Alexandrova et al.
CELL DEATH & DISEASE (2017)
ICAM-1 regulates macrophage polarization by suppressing MCP-1 expression via miR-124 upregulation
Wei Gu et al.
ONCOTARGET (2017)
A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model
Salema Jafri et al.
SCIENTIFIC REPORTS (2017)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
Dawid Walerych et al.
NATURE CELL BIOLOGY (2016)
Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers
Alexandre Rouette et al.
SCIENTIFIC REPORTS (2016)
Epidemiology of Prostate Cancer
Muhammad Naeem Bashir
Asian Pacific Journal of Cancer Prevention (2015)
Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia
Jennifer C. Rodger et al.
BJU INTERNATIONAL (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Matthew K. H. Hong et al.
NATURE COMMUNICATIONS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Mechanisms navigating the TGF-β pathway in prostate cancer
Zheng Cao et al.
ASIAN JOURNAL OF UROLOGY (2015)
The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele
Y. Shetzer et al.
CELL DEATH AND DIFFERENTIATION (2014)
Prostate cancer in young men: an important clinical entity
Claudia A. Salinas et al.
NATURE REVIEWS UROLOGY (2014)
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner
Sue Haupt et al.
CELL CYCLE (2013)
Genetically engineered mouse models of prostate cancer
Maxime Parisotto et al.
MOLECULAR ONCOLOGY (2013)
Use of PB-Cre4 Mice for Mosaic Gene Deletion
Andreas Birbach
PLOS ONE (2013)
Tumour-associated mutant p53 drives the Warburg effect
Cen Zhang et al.
NATURE COMMUNICATIONS (2013)
Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality
Xiaodong Sun et al.
GENESIS (2012)
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer
Paola Tucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition
Philip Martin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53 TARGETING WARBURG EFFECT TO FIGHT CANCER
Joanna Zawacka-Pankau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Hongwu Zheng et al.
NATURE (2008)
Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: A retrospective radiological review and implications for prostate and pelvis radiotherapy
ASN Jackson et al.
CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Pten dose dictates cancer progression in the prostate
LC Trotman et al.
PLOS BIOLOGY (2003)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation
XT Wu et al.
MECHANISMS OF DEVELOPMENT (2001)
分享论文
